Carlos Daniel Cordero-Rivera

11PUBLICATIONS
28CO-AUTHORS
Major global burdens of diseaseCellular interactions (incl. adhesion, matrix, cell wall)Medical infection agents (incl. prions)Veterinary parasitologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 27, 2026
Small extracellular vesicles from DENV2-infected C6/36 cells show viral infection in vitro and in vivo.

Carlos D Cordero-Rivera, Magda L Benítez-Vega, Selvin N Palacios-Rápalo

|Oct 29, 2025
Lipids, Tetraspanins, and Exosomes: Cell Factors in Orthoflavivirus Replication and Propagation.

Magda L Benitez-Vega, Carlos D Cordero-Rivera, Jose De Jesus Bravo-Silva

|Jun 27, 2025
Marine-Derived Peptides from Phaeodactylum tricornutum as Potential SARS-CoV-2 Mpro Inhibitors: An In Silico Approach.

David Mauricio Cañedo-Figueroa, Marco Antonio Valdez-Flores, Claudia Desireé Norzagaray-Valenzuela

|Aug 28, 2024
Antiviral Effect of Microalgae Phaeodactylum tricornutum Protein Hydrolysates against Dengue Virus Serotype 2.

Bianca Vianey Rivera-Serrano, Sandy Lucero Cabanillas-Salcido, Carlos Daniel Cordero-Rivera

|Feb 24, 2024
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin.

Luis Adrián De Jesús-González, Rosa María Del Ángel, Selvin Noé Palacios-Rápalo

|Dec 23, 2023
The Role of Aspartate Aminotransferase-to-Lymphocyte Ratio Index (ALRI) in Predicting Mortality in SARS-CoV-2 Infection.

José Manuel Reyes-Ruiz, Omar García-Hernández, Gustavo Martínez-Mier

Pageof 2